デフォルト表紙
市場調査レポート
商品コード
1480708

超崩壊剤の世界市場

Superdisintegrants

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.13円
超崩壊剤の世界市場
出版日: 2024年05月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

超崩壊剤の世界市場は2030年までに5億6,720万米ドルに達する見込み

2023年に3億9,470万米ドルと推定される超崩壊剤の世界市場は、2023年から2030年にかけてCAGR 5.3%で成長し、2030年には5億6,720万米ドルに達すると予測されます。本レポートで分析されているセグメントの1つである合成超崩壊剤は、CAGR 6.6%を記録し、分析期間終了時には2億6,220万米ドルに達すると予測されています。Natural 超崩壊剤セグメントの今後7年間のCAGRは5.2%と予測されています。

米国市場は1億480万米ドルと推定、中国はCAGR 9.3%で成長予測

米国の超崩壊剤市場は、2023年に1億480万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年までの分析期間においてCAGR 9.3%で推移し、2030年には1億3,450万米ドルの市場規模に達すると予測されています。その他の注目すべき地域市場としては、日本とカナダがあり、それぞれ2023年から2030年にかけて2%と5.5%の成長が予測されています。欧州では、ドイツがCAGR約2.5%で成長すると予測されています。オーストラリア、インド、韓国などの国々が牽引するアジア太平洋市場は、2030年までに7,720万米ドルに達すると予測されています。

2024 年の魅力的な新しいレポート機能のご紹介

インフルエンサーのエンゲージメント統計へのフルアクセス

デジタルアーカイブと「MarketGlass」調査プラットフォームへの無料アクセス。当社独自のMarketGlassプラットフォームは、世界中の専門家の創造性と市場知識を統合的かつ協調的に解き放つことができます。当社の最先端のツールは、市場参入企業のプライバシーとアイデンティティを保護しながら、世界クラスの市場展望をもたらします。レポート内の数字、統計、市場に関する説明は、この分野の専門家や影響力のある人々によって共有された、完全にキュレートされた洞察に基づいています。

リアルタイムのデータシミュレーター・ツールや特注のレポート作成機能を備えたインタラクティブなアンケートに参加できます。

企業間のスマートな意見交換のためのピアコラボレーティブ・インタラクティブプラットフォームへのフルクライアントアクセス

1年間の無料レポート更新

主要プレーヤーの世界市場シェアを含む競合カバレッジ

複数の地域にまたがるプレーヤーの市場プレゼンス分析(好調/活発/ニッチ/マイナー)

専門家/インフルエンサーのインタビュー、ポッドキャスト、報道発表、イベント基調講演のYouTubeビデオへのアクセス

2024年の世界経済に期待すること

金融引き締めとそれに伴う金利上昇によって引き起こされる地政学的、経済的不安定性が、2024年の激動の情勢を作り出すと思われます。中東での敵対行為や、ますます頻発する気候災害など、いくつかの要因が回復への道筋に圧力をかけ続けると思われます。リスクの一方で、ディスインフレの兆候が強まり、頑迷なインフレに対する不安が緩和され、サプライチェーンが正常化し、エネルギーコストの変動にもかかわらず物価が緩やかになるなど、いくつかのプラス材料も具体化しつつあります。インドや米国をはじめとするG21諸国の選挙は、資本の流れや投資戦略に影響を与える可能性があります。インドが世界な投資先として注目される一方で、米国を拠点とするハイテク企業は、才能と資本のダイナミックなエコシステムに後押しされ、引き続き優位を保つと思われます。シリコンバレーをはじめとするハイテク機会は、国内経済が減速しているとはいえ底堅く、規制環境も整備されていることから、高成長の可能性を求める投資家にとって引き続き魅力的です。欧州は金融引き締め政策と景気後退リスクとの戦いが続くが、英国は見通しが最も厳しく、2024年の景気後退リスクが最も高いです。中国は、政府支出と個人消費の改善に支えられた成長が期待されるもの、引き続きワイルドカードとなります。不安定な環境は、投資家にも企業にもチャンスと課題の両方をもたらすと思われます。成長への触媒としてボラティリティを受け入れるとともに、敏捷性と戦略的な先見性をもって投資判断に臨むことが、生き残りのために重要であることに変わりはないです。

調査対象企業の例(全46件)

  • Asahi Kasei Corporation
  • Ashland Global Holdings, Inc.
  • Avantor Performance Materials LLC
  • BASF SE
  • Corel Pharma Chem
  • DFE Pharma GmbH & Co. KG
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Jrs Pharma GmbH Co. KG
  • Merck KgaA
  • Roquette Freres S.A.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15079

Global Superdisintegrants Market to Reach $567.2 Million by 2030

The global market for Superdisintegrants estimated at US$394.7 Million in the year 2023, is expected to reach US$567.2 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Synthetic Superdisintegrants, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$262.2 Million by the end of the analysis period. Growth in the Natural Superdisintegrants segment is estimated at 5.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $104.8 Million, While China is Forecast to Grow at 9.3% CAGR

The Superdisintegrants market in the U.S. is estimated at US$104.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$134.5 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 5.5% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$77.2 Million by the year 2030.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 46 Featured) -

  • Asahi Kasei Corporation
  • Ashland Global Holdings, Inc.
  • Avantor Performance Materials LLC
  • BASF SE
  • Corel Pharma Chem
  • DFE Pharma GmbH & Co. KG
  • Dow, Inc.
  • DuPont de Nemours, Inc.
  • Jrs Pharma GmbH Co. KG
  • Merck KgaA
  • Roquette Freres S.A.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Superdisintegrants - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Natural Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Natural Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Natural Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Synthetic Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Synthetic Superdisintegrants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Synthetic Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Superdisintegrants Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • JAPAN
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • CHINA
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • EUROPE
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Superdisintegrants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Superdisintegrants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • FRANCE
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • GERMANY
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Superdisintegrants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Superdisintegrants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • INDIA
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Superdisintegrants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Superdisintegrants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Superdisintegrants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Superdisintegrants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Superdisintegrants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030
  • AFRICA
    • Superdisintegrants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Superdisintegrants by Product - Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Superdisintegrants by Product - Percentage Breakdown of Value Sales for Synthetic Superdisintegrants, Natural Superdisintegrants and Other Products for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Superdisintegrants by Therapeutic Area - Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Superdisintegrants by Therapeutic Area - Percentage Breakdown of Value Sales for Neurology, Cardiovascular, Gastrointestinal, Oncology and Other Therapeutic Areas for the Years 2014, 2024 & 2030

IV. COMPETITION